>>

>>

抑制剂/激活剂

>>

凋亡与自噬

>>

GW9662

GW9662是一种选择性PPAR拮抗剂，作用于PPARγ，无细胞试验中IC50为3.3 nM，在细胞中作用于PPARγ比作用于PPARα和PPARδ的功能选择性强10到600倍。

货号：
TK0283
规格：

1mg

5mg

10mg

25mg
价格：
￥0.00

产品参数

CAS No.	22978-25-2
生物活性	GW9662 is a potent and selective PPARγ antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively.
分子式	C13H9ClN2O3
分子量	276.68
储存条件	Powder -20℃ 3 years
溶解性数据	DMSO : ≥ 100 mg/mL (361.43 mM) H2O : < 0.1 mg/mL (insoluble)
体内研究	Bone marrow (BM) nucleated cell counts in both BADGE- and GW9662(1 mg/kg, i.p.)-treated mice are significantly higher than counts in the aplastic anemia (AA) group. GW9662 (1 mg/kg, i.p.) largely attenuates the renoprotective effects of Lipopolysaccharide (LPS) in the rat.
体外研究	GW9662 inhibits radioligand binding to PPARγ, PPARα, and PPARδ with pIC50s of 8.48±0.27 (IC50=3.3 nM; n=10), 7.49±0.17 (IC50=32 nM; n=9), and 5.69±0.17 (IC50=2000 nM; n=3), respectively. GW9662 has nanomolar IC50 versus PPARγ and is 10- and 600-fold less potent in binding experiments using PPARα and PPARδ, respectively. In cell-based reporter assays, GW9662 is a potent and selective antagonist of full-length PPARγ. Co-treatment with both 50 μM BRL 49653 and 10 μM GW9662 results in statistically lower viable cell numbers after 7 days when compared to treatment with either 50 μM BRL 49653 (P=0.001) or 10 μM GW9662 (P=0.01) alone.
文献	暂无相关参考文献
纯度及产品资料	98%

推荐产品